Similar Papers

Paper Title
Journal
Date
Author
Tumor Necrosis Factor-α Blockade and Development of Uveal Melanoma: Expected Adverse Effect or Just Coincidence?
Takami Sato
Mayo Clinic Proceedings | VOL. 89
Takami SatoTakami Sato
01 Nov 2014
Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
Tim Bongartz ... Iain Buchan
JAMA | VOL. 295
Tim Bongartz, et. al.Tim Bongartz ... Iain Buchan
17 May 2006
THU0387 The clinical importance of the thyroid nodules during tumor necrosis factor-alpha inhibitor therapy in patients with axial spondyloarthritis
R Terlemez ... H Sarı
Annals of the Rheumatic Diseases | VOL. 76
R Terlemez, et. al.R Terlemez ... H Sarı
01 Jun 2017
SAT0170 Risk of Skin Cancer Following Anti-Tumour Necrosis Factor Treatment in Rheumatoid and Psoriatic Arthritis: A Systematic Literature Review
R Chatterjea ... M Mc Laughlin
Annals of the Rheumatic Diseases | VOL. 74
R Chatterjea, et. al.R Chatterjea ... M Mc Laughlin
01 Jun 2015
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the rheumatic diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
20 Dec 2024
2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the Rheumatic Diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
19 Dec 2024
Contents
-
Annals of the Rheumatic Diseases | VOL. 83
--
01 Dec 2024
Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults
Elizabeth M Winter ... Anne T Leerling
Annals of the Rheumatic Diseases | VOL. -
Elizabeth M Winter, et. al.Elizabeth M Winter ... Anne T Leerling
28 Nov 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.